The collaboration seeks to improve the delivery of life-changing medicines that are fueling growth in the industry and providing value to patients.
The centerpiece of the program is the AZhelps mobile app, available on iOS and Android devices, that allows users to save and track their medications.
The app will help clinicians and patients manage side effects of hypertension and diarrhoea, which can be associated with therapy with cediranib and olaparib.
With Adherium's smartphone-connected device, the medication adherence increases by up to 59% in adults and 180% in children with asthma.
Whereas users are typically required to pay $49 per month, select patients in participating hospitals will be able to use the new Day-by-Day app for free.
The parties will work together to create the next generation of cutting-edge innovations leading to a portfolio of pioneering digital health ventures.
AstraZeneca wants to use patient-reported data from PatientsLikeMe to shape future medicine development and help improve outcomes across therapeutic areas.